CS114290A3 - Specifically glycosylated insulin derivatives - Google Patents

Specifically glycosylated insulin derivatives Download PDF

Info

Publication number
CS114290A3
CS114290A3 CS901142A CS114290A CS114290A3 CS 114290 A3 CS114290 A3 CS 114290A3 CS 901142 A CS901142 A CS 901142A CS 114290 A CS114290 A CS 114290A CS 114290 A3 CS114290 A3 CS 114290A3
Authority
CS
Czechoslovakia
Prior art keywords
insulin
glycosylated insulin
residues
specifically
human
Prior art date
Application number
CS901142A
Other languages
Czech (cs)
English (en)
Inventor
John Broberg Halstrom
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of CS114290A3 publication Critical patent/CS114290A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CS901142A 1989-03-08 1990-03-08 Specifically glycosylated insulin derivatives CS114290A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK111489A DK111489D0 (da) 1989-03-08 1989-03-08 Peptider

Publications (1)

Publication Number Publication Date
CS114290A3 true CS114290A3 (en) 1992-02-19

Family

ID=8101165

Family Applications (1)

Application Number Title Priority Date Filing Date
CS901142A CS114290A3 (en) 1989-03-08 1990-03-08 Specifically glycosylated insulin derivatives

Country Status (19)

Country Link
EP (1) EP0462192A1 (de)
JP (1) JPH04504117A (de)
KR (1) KR920701249A (de)
CN (1) CN1045586A (de)
AU (1) AU638701B2 (de)
CA (1) CA2049937A1 (de)
CS (1) CS114290A3 (de)
DD (1) DD296933A5 (de)
DK (1) DK111489D0 (de)
FI (1) FI914226A0 (de)
GR (1) GR1000604B (de)
HU (1) HUT59942A (de)
IL (1) IL93674A0 (de)
NO (1) NO913517L (de)
NZ (1) NZ232808A (de)
PT (1) PT93366A (de)
WO (1) WO1990010645A1 (de)
YU (1) YU45490A (de)
ZA (1) ZA901737B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2552043A1 (en) 2004-01-21 2005-08-04 Novo Nordisk A/S Transglutaminase mediated conjugation of peptides
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
US8846103B2 (en) 2009-01-28 2014-09-30 Smartcells, Inc. Exogenously triggered controlled release materials and uses thereof
WO2010088294A1 (en) 2009-01-28 2010-08-05 Smartcells, Inc. Conjugate based systems for controlled drug delivery
CA2750269A1 (en) 2009-01-28 2010-08-05 Smartcells, Inc. Crystalline insulin-conjugates
US8569231B2 (en) 2009-03-20 2013-10-29 Smartcells, Inc. Soluble non-depot insulin conjugates and uses thereof
AU2010226243A1 (en) 2009-03-20 2011-09-22 Smartcells, Inc. Terminally-functionalized conjugates and uses thereof
EP2598170A4 (de) 2010-07-28 2016-07-06 Smartcells Inc Arzneimittel-liganden-konjugate, deren synthese und zwischenprodukte daraus
JP2013535467A (ja) 2010-07-28 2013-09-12 スマートセルズ・インコーポレイテツド 組換えにより発現されたインスリンポリペプチドおよびその使用
JP2013541500A (ja) 2010-07-28 2013-11-14 スマートセルズ・インコーポレイテツド 組換えレクチン、結合部位修飾レクチンおよびそれらの用途
US9624287B2 (en) 2012-07-17 2017-04-18 Case Western Reserve University O-linked carbohydrate-modified insulin analogues
EP2877200B1 (de) * 2012-07-17 2019-05-08 Case Western Reserve University O-verknüpfte kohlenhydratmodifizierte insulinanaloga
AU2013346624B2 (en) 2012-11-13 2018-08-09 Adocia Quick-acting insulin formulation including a substituted anionic compound
CA2890048C (en) 2012-12-03 2022-05-03 Merck Sharp & Dohme Corp. O-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
JP6410790B2 (ja) 2013-03-14 2018-10-24 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ミトコンドリアアルデヒドデヒドロゲナーゼ−2調節因子およびその使用方法
AU2014329567B2 (en) 2013-10-04 2019-07-25 Merck Sharp & Dohme Corp. Glucose-responsive insulin conjugates
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
CN105709207A (zh) 2016-01-29 2016-06-29 徐宝贞 一种用于治疗痛风的药物
CN105535927A (zh) * 2016-01-29 2016-05-04 山东中海制药有限公司 一种用于治疗流感、上呼吸道感染、病毒性肺炎的药物
CN105597080A (zh) * 2016-01-29 2016-05-25 程潜 一种用于治疗尿毒症和尿蛋白的药物
CN109562185A (zh) 2016-06-02 2019-04-02 赛诺菲 药剂与能够结合葡萄糖感应蛋白的部分的新颖缀合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3847890A (en) * 1971-11-01 1974-11-12 A Green Acidic monosaccharide-substituted proteins
US4444683A (en) * 1982-11-17 1984-04-24 University Of Utah Glycosylated insulin derivatives
EP0119650A3 (de) * 1983-03-21 1987-09-30 THE PROCTER & GAMBLE COMPANY Galactosyl-Insulin-Konjugate für die Behandlung von Zuckerkranken
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components

Also Published As

Publication number Publication date
GR1000604B (el) 1992-08-26
CN1045586A (zh) 1990-09-26
AU638701B2 (en) 1993-07-08
AU5280790A (en) 1990-10-09
KR920701249A (ko) 1992-08-11
WO1990010645A1 (en) 1990-09-20
EP0462192A1 (de) 1991-12-27
NZ232808A (en) 1992-04-28
JPH04504117A (ja) 1992-07-23
GR900100159A (en) 1990-07-31
IL93674A0 (en) 1990-12-23
NO913517L (no) 1991-11-06
YU45490A (en) 1991-10-31
PT93366A (pt) 1990-11-07
NO913517D0 (no) 1991-09-06
DK111489D0 (da) 1989-03-08
HUT59942A (en) 1992-07-28
DD296933A5 (de) 1991-12-19
ZA901737B (en) 1990-11-28
CA2049937A1 (en) 1990-09-09
HU902787D0 (en) 1991-11-28
FI914226A0 (fi) 1991-09-06

Similar Documents

Publication Publication Date Title
CS114290A3 (en) Specifically glycosylated insulin derivatives
Spiro Studies on the renal glomerular basement membrane: preparation and chemical composition
Volpin et al. Cyanogen bromide peptides from insoluble skin and dentin bovine collagens
US9452224B2 (en) Sialic acid derivatives for protein derivatisation and conjugation
JP4416184B2 (ja) 長期作用型薬物およびこれらを含む薬剤組成物
US6908897B2 (en) Covalently bridged insulin dimers
EP0119650A2 (de) Galactosyl-Insulin-Konjugate für die Behandlung von Zuckerkranken
MX2011000847A (es) Proteinas conjugadas con eficacia prolongada in vivo.
WO2005041865A2 (en) Compounds and method for treating cancer
IE910579A1 (en) Novel protein compositions
EP0128097B1 (de) Immunostimulierende Derivate, ihre Herstellung und ihre Verwendung als Arzeimittel
AU608512B2 (en) Sulfated polysaccharide
US6274558B1 (en) Method for treating cardiac malfunction
AU2008303584B2 (en) Glycoproteins and glycosylated cells and a method for the preparation of the same
Kozulić et al. Study of the carbohydrate part of yeast acid phosphatase
JP2018506576A (ja) 多価リガンド−脂質構築物
Ito et al. Structural study of the oligosaccharide moieties of sphingolipid activator proteins, saposins A, C and D obtained from the spleen of a Gaucher patient
Goussault et al. Chemical characterization of two urinary sialic acid-rich glycopeptides
USRE32347E (en) Hypocalcaemic peptides and process for their manufacture
JPH09309842A (ja) 新規な生理活性物質、その製造方法及び医薬組成物
JP2729201B2 (ja) アミド結合を持ったシアル酸誘導体
Koeners et al. Synthesis of 0-(2-0-α-d-glucopyranosyl)-β-d-galactopyranoside of optically pure δ-hydroxy-l-lysylglycine and-gd-hydroxy-l-lysylglycyl-l-glutamyl-l-aspartylglycine: Components of the glomerular basement membrane
Vicari et al. Immunochemical studies on blood groups. XLV. Structures and activities of oligosaccharides produced by alkaline degradation of a blood group substance lacking A, B, H, Lea, and Leb specificities
JP2714430B2 (ja) Na,K―ATPase阻害作用を有する新規ペプタイド
US20040077845A1 (en) Modifier